Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
On-demand Webinar: Optimize research and delivery of complex medicines using data insights
Event Overview: The Life Sciences industry relies on vast amounts of data to rapidly evaluate their novel therapies confidently at a global scale. To...
Developing New Medicines Through Artificial Intelligence
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
As biopharma companies outsource more specialized activity to CDMOs, successful technology transfer becomes even more integral to project success. To...
Resilience builds lab supply chain tracking platform on AWS
by Adam Mendez, Alissa Gordon, and Lee Tessler Originally published on AWS | 27 NOV 2023 We would like to acknowledge the valuable contributions of...
.jpeg)
How digital twins help improve biomanufacturing quality and security
Biomanufacturing safety and efficacy depend on well-controlled, compliant manufacturing processes. Can a virtual model truly give biomanufacturing...
